コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 tional group in medicinal chemistry and drug discovery.
2 emerging approach in modern anticancer drug discovery.
3 ty-building in global marine natural product discovery.
4 t identification is a major obstacle in drug discovery.
5 epresent a new era for noninvasive biomarker discovery.
6 standing challenges in natural products drug discovery.
7 e, and to continue the pursuit of novel drug discovery.
8 s structural biology, cell imaging, and drug discovery.
9 diagnostics, functional proteomics, and drug discovery.
10 ollowed by sequencing analysis and DNA motif discovery.
11 WAS) are still the primary steps toward gene discovery.
12 ent the relevance of peptidomimetics in drug discovery.
13 a comprehensive strategy for natural product discovery.
14 processes is an important first step of drug discovery.
15 great promise for disease modeling and drug discovery.
16 ancer, and is an important biomarker in drug discovery.
17 technologies to enable next-generation drug discovery.
18 rs in recombinant systems has precluded drug discovery.
19 ys in the early ADME profiling space in drug discovery.
20 promising characteristics as sources for NP discovery.
21 cs has led to an exponential growth in virus discovery.
22 ignificantly streamline therapeutic antibody discovery.
23 on and classification and advances biomarker discovery.
24 d protein chimeras have been used in epitope discovery.
25 interaction prediction and literature-based discovery.
26 subsequently be used in other tools for loop discovery.
27 have been a crucial component of many recent discoveries.
35 ys that were opened in neuroscience by major discoveries and set the stage for the next 50 years.
38 Ls represents a significant challenge to the discovery and characterization of biologically relevant
39 mixture analysis and subsequent accelerated discovery and characterization of new natural products.
42 of mitophagy pathways and prospects for drug discovery and consider intervention points for mitophagy
43 te and describes novel opportunities for the discovery and development of drugs for metabolic reprogr
44 lation is an attractive target for antiviral discovery and development of new live attenuated vaccine
47 ges the current paradigm of traditional drug discovery and development, which usually takes years fro
48 anels provide genetic resolution for variant discovery and functional characterization, as well as di
55 present an integrated approach to materials discovery and qualification to insert new materials into
61 l molecules suitable for fragment-based drug discovery and the cystic fibrosis C2-corrector clinical
66 t-generation" approaches that are needed for discovery and understanding but that do not always fit n
67 ics in nephrology has largely focused on the discovery and validation of biomarkers, but the systemat
68 select the proper controls to minimize false discoveries, and experimental variations among biologica
69 nonconventional organisms have had in these discoveries, and outline new avenues of investigation to
70 ed the best trade-off between true and false discoveries, and this advantage is more apparent in data
71 l variants, we present two methods of driver discovery, and identify regions that are significantly a
77 gh it provides invaluable resources for drug discovery as well as understanding of disease mechanisms
78 hese findings are critical for rational drug discovery, as limiting a virtual screen to a single conf
79 enable realistic physical models and advance discovery at the interface of geometry and cellular proc
82 This work will not only fuel kinase degrader discovery, but also provides a blueprint for evaluating
83 udy of such processes, as well as the recent discoveries by leading investigators with an emphasis on
92 s: HR 1.24, 95% CI 1.02-1.51; p=0.034 in the discovery dataset; 1.10, 0.98-1.20; p=0.10 in the valida
93 ble hematologic malignancy, as an incidental discovery during molecular analysis of a nonhematologic
94 have provided an up-to-date account of drug discovery efforts targeting selected enzymes (MbtI, MbtA
101 n autoimmunity and the importance of antigen discovery for improved understanding of disease mechanis
112 hin the nervous system have intersected with discoveries in immunology in unexpected ways to rapidly
113 s will benefit from understanding the latest discoveries in neutrophil biology and how these novel fu
118 form, which enables high-throughput reaction discovery in flow to generate pharmaceutically relevant
120 y's activities, with the intent of enhancing discovery in public health." As a foundational step in i
122 gies have recently fueled an exciting era of discovery in the field of chromosome structure and nucle
124 hanisms and on the approaches for biomarkers discovery is also provided, including genetic studies an
126 Zebrafish models are a powerful system for discovery, live imaging, and functional investigation of
128 yping and wearable technologies, and how new discovery may be advanced through machine learning appro
130 from the Psychiatric Genomics Consortium for discovery (N=19,210) and ADHD data from the Lundbeck Fou
132 may contribute an understanding to previous discoveries of RV activation in ALS affected patients.
136 sting of 62 screening candidates yielded the discovery of 10 new agonist chemotypes with sub-micromol
139 These mechanistic insights assisted the discovery of a new Ti(salen) catalyst, which substantial
141 The hit-to-lead optimization led to the discovery of a novel chemotype series exemplified by the
142 ucture-activity relationship, leading to the discovery of a novel DBO, ANT3310, which uniquely has a
143 ed colorimetric readout of this assay to the discovery of a novel monoclonal antibody (mAb) sandwich
148 e 2-sulfonylpyridine reactive group with the discovery of a selective covalent modifier of adenosine
150 tively, is identified, which accelerates the discovery of a series of new oxide perovskite catalysts
154 process on a synthetic scale, leading to the discovery of an Amadori-type rearrangement of dopegal in
157 case under the HOPE Act at our center where discovery of an HIV-specific issue led to a turndown of
160 ectional circuits.SIGNIFICANCE STATEMENT The discovery of anterograde transneuronal spread of AAV1 ge
161 host interactions that should facilitate the discovery of antiviral drugs for this important zoonotic
163 S. tora reference genome will accelerate the discovery of biologically active anthraquinone biosynthe
166 rmeability, and low efflux culminated in the discovery of compound 1, which exhibited target engageme
170 eening strategy, which can lead to the rapid discovery of drug leads with clinical potential in respo
171 the progression of liver diseases and in the discovery of drugs for the treatment of these disorders.
172 ected to facilitate rational structure-based discovery of drugs targeting the cannabinoid system.
177 has led to important insights, including the discovery of guidance rules that attacking predators use
184 ncluding novel ligand identification and the discovery of loss-of-function mutations associated with
186 bstantial additional insights, including the discovery of mechanisms that trigger and propagate kidne
188 These findings will help efforts towards the discovery of microbial-derived repellent/oviposition-det
190 -coupled receptors, has directly enabled the discovery of most drugs developed to modulate receptor s
191 as a valuable experimental platform for the discovery of much-needed novel therapeutic targets in th
193 rise of antibiotic resistance and declining discovery of new antibiotics has created a global health
194 fraction studies up to 27 GPa, we report the discovery of new high-pressure polymorphs of the feldspa
195 lp to deepen our understanding and guide the discovery of next-generation water harvesting materials.
198 small molecule libraries (DELs) have enabled discovery of novel inhibitors for many distinct protein
201 t the global rise in metabolic syndrome, the discovery of novel signaling roles for metabolites, and
206 he development of which will be aided by the discovery of potent and selective antibodies against rel
209 ew material and the holotype, leading to the discovery of several new morphological features, such as
210 q data, presenting analytical challenges for discovery of somatic indels in tumor transcriptome.
211 f chromosome-scale phased assemblies for the discovery of structural variants (SVs), including thousa
213 ethods have been developed to facilitate the discovery of such non-classical secreted proteins; howev
215 y Rolf Kemler and Masatoshi Takeichi for the discovery of the cadherin family of Ca(2+)-dependent cel
216 hlight issues and perspectives raised by the discovery of the first pharmaceutical strongly affecting
222 ctivity, and oral bioavailability led to the discovery of the potent, highly selective, orally availa
223 w dominate previously coral-rich reefs.(6-8) Discovery of the powerful grazing capability of the Cari
230 A strategic screening approach led to the discovery of this novel ligand, which was successfully a
233 This strategy may also be employed for the discovery of unconventional spherical assemblies in othe
234 asma cells and plasmablasts could enable the discovery of useful antibodies for therapeutic or resear
236 and RyR2, in addition to the impact of such discoveries on intracellular Ca(2+) dynamics and biophys
248 peline provides a roadmap for rapid antibody-discovery programmes against viral pathogens of global c
249 eletal ring systems is of importance to drug discovery programmes and natural product synthesis.
252 s successfully used in several 'inverse drug discovery' programs that use high-throughput techniques
258 cant enrichments across nine diseases (false discovery rate < 0.05) (for example, NKX3-1 for prostate
260 ic traits in cross-sectional analyses (false discovery rate <0.10), and 8 of these proteins had pQTLs
264 introduce an extension of the Irreproducible Discovery Rate (IDR) method called IDR2D that identifies
266 sting following the Benjamini-Hochberg false discovery rate [FDR] showed that 18 miRNAs were signific
268 te a broad assessment of the empirical false discovery rate across other subject areas and characteri
271 , 95% CI - 0.015, 0.046, adjusted mean false discovery rate Open Access = 0.241 vs. closed access = 0
273 cally significant evidence of a higher false discovery rate, on average, for Open Access versus close
274 imulation (TMS) for treatment of depression (discovery sample, N=30; active replication sample, N=81;
275 broad audience; applications can range from discovery science through clinical trials to clinical pr
282 ation-profiling approach will enable further discoveries that change the natural history of CF lung d
283 c strategy toward 4 and report the series of discoveries that prompted the design of this cascade cou
284 ent examples of de novo biosynthetic pathway discovery that employ various innovative approaches.
286 ction between these two pathways through our discovery that human aminolevulinic acid dehydratase (AL
294 ed virtual screening and fragment-based drug discovery to identify compounds likely to bind PRLR and
295 ic access to leubethanol will enable pathway discovery to more complex serrulatane diterpenoids which
296 fer an overview of studies focusing on miRNA discovery using profiling techniques and bioinformatic m
297 s and educators working in the areas of drug discovery, vaccine design, and biomedical and biotechnol
299 sent and future value of simulation for drug discovery, we review key applications of advanced method
300 lysis platform that couples dominant pattern discovery with a corresponding structural representation